-
2
-
-
69549097985
-
Prevalence of erythromycin and quinolone resistant Clostridium difficile strain 001 in Southern Germany
-
19057
-
Borgmann S., M. Kist, T. Jakobiak, M. Reil, E. Scholz, C. von Eichel-Streiber, H. Gruber, J.S. Brazier and B. Schulte. 2008. Prevalence of erythromycin and quinolone resistant Clostridium difficile strain 001 in Southern Germany. Euro. Surveill. 13(49): pii: 19057.
-
(2008)
Euro. Surveill.
, vol.13
, Issue.49
-
-
Borgmann, S.1
Kist, M.2
Jakobiak, T.3
Reil, M.4
Scholz, E.5
Von Eichel-Streiber, C.6
Gruber, H.7
Brazier, J.S.8
Schulte, B.9
-
3
-
-
33748046475
-
European surveillance of antimicrobial consumption (ESAC): Outpatient antibiotic use in Europe
-
ESAC Project Group
-
Ferech M., S. Coenen, S. Malhotra-Kumar, K. Dvorakov, E. Hendrickx, C. Suetens, H. Goossens and ESAC Project Group. 2006. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe. J. Antimicrob. Chemother. 58: 401-407.
-
(2006)
J. Antimicrob. Chemother.
, vol.58
, pp. 401-407
-
-
Ferech, M.1
Coenen, S.2
Malhotra-Kumar, S.3
Dvorakov, K.4
Hendrickx, E.5
Suetens, C.6
Goossens, H.7
-
4
-
-
33947537711
-
Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries
-
European Surveillance of Antimicrobial Consumption Project Group
-
Goossens H., M. Ferech, S. Coenen, P. Stephens and European Surveillance of Antimicrobial Consumption Project Group. 2006. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin. Infect. Dis. 44: 1091-1095.
-
(2006)
Clin. Infect. Dis.
, vol.44
, pp. 1091-1095
-
-
Goossens, H.1
Ferech, M.2
Coenen, S.3
Stephens, P.4
-
5
-
-
13844254907
-
Outpatient antibiotic use in Europe and association with resistance: A cross-national database study
-
DOI 10.1016/S0140-6736(05)17907-0
-
Goossens H., M. Ferech, R. Vander Stichele, M. Elseviers and ESAC Project Group. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579-587. (Pubitemid 40247914)
-
(2005)
Lancet
, vol.365
, Issue.9459
, pp. 579-587
-
-
Goossens, H.1
Ferech, M.2
Vander Stichele, R.3
Elseviers, M.4
-
6
-
-
33749842452
-
Regional variation in outpatient antibiotic prescribing in Germany
-
Kern W.V., K. de With, K. Nink, M. Steib-Bauert, H. Schröder. 2006. Regional variation in outpatient antibiotic prescribing in Germany. Infection 34: 269-273.
-
(2006)
Infection
, vol.34
, pp. 269-273
-
-
Kern, W.V.1
De With, K.2
Nink, K.3
Steib-Bauert, M.4
Schröder, H.5
-
7
-
-
69549116968
-
4. Antibiotic resistance in human medicine (in German) 4.1.4. Haemophilus influenzae
-
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. Antiinfectives Intelligence, Gesellschaft für klinisch- mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
-
Kresken M. and Straube E. 2008. 4. Antibiotic resistance in human medicine (in German) 4.1.4. Haemophilus influenzae. In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany.
-
(2008)
GERMAP 2008. Antibiotic Resistance and Consumption (In German)
-
-
Kresken, M.1
Straube, E.2
-
8
-
-
38449119949
-
European surveillance of antimicrobial consumption (ESAC): Outpatient antibiotic use in Europe, 1998-2005
-
ESAC project group
-
Muller A., S. Coenen, D.L. Monnet, H. Goossens and ESAC project group. 2007. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Euro. Surveill. 12: E071011.1.
-
(2007)
Euro. Surveill.
, vol.12
-
-
Muller, A.1
Coenen, S.2
Monnet, D.L.3
Goossens, H.4
-
9
-
-
69549101696
-
Antibiotic consumption in human medicine. 2.1. Antibiotic consumption in ambulalatory settings
-
in German. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft fur Chemotherapie e.V., 8. Infektiologie Freiburg Eds. Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
-
Schröder H. and Kern W.V. 2008 Antibiotic consumption in human medicine. 2.1. Antibiotic consumption in ambulalatory settings (in German). In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft fur Chemotherapie e.V., 8. Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany.
-
(2008)
GERMAP 2008. Antibiotic Resistance and Consumption (In German)
-
-
Schröder, H.1
Kern, W.V.2
-
10
-
-
69549122128
-
4. Antibiotic resistance in human medicine (in German). 4.1.1. Streptococcus spec
-
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. Antiinfectives Intelligence, Gesellschaft für klinisch- mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
-
Van der Linden M., M. Imöhl and M.M. Reinert. 2008.4. Antibiotic resistance in human medicine (in German). 4.1.1. Streptococcus spec. In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany.
-
(2008)
GERMAP 2008. Antibiotic Resistance and Consumption (In German)
-
-
Van Der Linden, M.1
Imöhl, M.2
Reinert, M.M.3
|